C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-peptide concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.
Application
C-peptide is a substance produced by the pancreas, along with insulin. Insulin is a hormone that controls the body's glucose (blood sugar) levels. Glucose is the primary source of energy for the body. If the body does not produce the appropriate amount of insulin, it may be an indication of diabetes.
C-peptide and insulin are released from the pancreas simultaneously and in approximately equal amounts. As a result, a C-peptide test can provide insights into the body's insulin production levels. This test can be a useful way to measure insulin levels because C-peptide tends to remain in the body for a longer duration compared to insulin.
The key advantage of using a C-peptide test is that it can offer a more accurate assessment of the body's insulin production capacity. Insulin itself is cleared from the bloodstream relatively quickly, making it more challenging to measure. In contrast, C-peptide has a longer half-life, providing a more reliable indicator of the pancreas's insulin-producing capabilities.
By analyzing C-peptide levels, healthcare providers can gain valuable information about the underlying cause of a patient's diabetes, which can inform the most appropriate treatment approach. This test can be particularly useful in differentiating between type 1 and type 2 diabetes, as well as in monitoring the progression of the disease and the effectiveness of insulin therapy.
In summary, the C-peptide test provides a valuable tool for healthcare professionals to assess and manage diabetes by offering insights into the body's insulin production and secretion dynamics.
Product Specification
Sample Volume |
WB: 20μL; Serum/Plasma: 10μL |
Test Time |
10 mins |
Measuring Range |
0.1- 40.00 ng/mL |
Pack |
20T、40T、100T |
Storage |
2~30℃ |
Features
Smart - Photosensitive and Luminescent Microspheres
Rapid - Whole Blood Sample Type Supported & No Centrifuge Needed
Convenient - Room Temperature Storage & Minimal sample consumption
Clinical significance
Assessment of Endogenous Insulin Production
Distinguishing Type 1 and Type 2 Diabetes
Monitoring Islet Cell Transplants
Assessment of Insulinoma
Evaluation of Hypoglycemia
Previous :
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)Next :
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)Please provide us with the information below, and we'll contact you as soon as possible.